RemeGen
688331----
Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: RemeGen(688331) the Revenue is 5.197 B (--%), Beat estimate;the EBIT is -624.91 M (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
5.20B--
2.69B--
+2.51B--%
EBITMiss expectations
-0.62B--
1.78B--
-2.40B--%
Upcoming earnings report - Q3 FY2026
Available dateOct 30, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf